ient to the possibility of such results in pretest patient discussions, clini- cal testing, and reporting of results. The ACMG appointed a Work- ing Group on Incidental Findings in Clinical Exome and Genuine Sequencing to make recommendations about responsible manage- ment of incidental findings when patients undergo exome o